In this longitudinal study, 220 participants were enrolled following recent onset of LBP and data was collected until the LBP resolved or until the end of the study at six months. Forty-two participants’ pain resolved prior to 6 weeks from onset and 42 participants continued to have pain at 6 months. Patient reported pain burden, somatosensory function (quantitative sensory testing) and blood samples were collected at each study visit.
CLBP is associated with greater pain burden and somatosensory hypersensitivity at the time of LBP onset. COMT rs4680 genotype (GG) was associated with acute cold pain sensitivity and with the risk for transition to CLBP while COMT expression was independently associated with risk for transition.
CLBP was characterized by higher reported pain burden and augmented hypersensitivity at LBP onset. COMT expression and genotype were associated with acute pain burden and likelihood of transition to CLBP.